Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 157
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
No Questions Asked: FDA’s Psychedelics Public Hearing
Definium Notches Second Positive Phase 3 in Generalised Anxiety Disorder
THE GATEWAY: Live From DC After the FDA Psychedelics Hearing
Approvals to Access: A Crude Schematic
Davis, Farchione and Colleagues Present FDA’s Psychedelic Drug Framework in NEJM
Free Webinar — Traditional and Modern Perspectives on Healing
atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a...
PT367 – Colorado Proposition 122 and the Decriminalization of Natural Medicines
Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs
Variants in 5-HT2A Receptor Gene Alter Psychedelic Pharmacology
Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University...
Psychedelic Bulletin #120: Beckley Psytech Acquires Eleusis; A Look at COMPASS’...
Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis...
Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s...
PT366 – Neurotransmitter Systems and Novel Psychedelic Molecules
Load more